Asthma pp 162-174 | Cite as

Management of bronchial asthma Summary of International Guidelines

  • Leonardo M. Fabbri
  • A. Papi
  • P. Boschetto
  • A. Ciaccia
Conference paper


Prof. L. M. Fabbri was member of the international expert group who provided a consensus paper on the management of asthma. Pharmacological therapy of asthma has become more potent, longer acting and better available. It should follow the strategies applied to steps of severity of the disease. Specific immunotherapy (IT) is not discussed here extensively, but it is stated that IT is under continual investigation. Its use, however is limited (younger persons, few and unavoidable allergens, totally reversible lung function).


Asthma Symptom Peak Expiratory Flow Rate Asthma Management Specific Immunotherapy Asthmatic Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Das Management der Asthmatherapie. Zusammenfassung internationaler Empfehlungen


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Woolcock AJ, Rubinfeld AR, Seale JP et al (1989) Asthma management plan. Med J Australia 151: 650–653PubMedGoogle Scholar
  2. 2.
    Barnes PJ (1989) A new approach to the treatment of asthma. N Engl J Med 321: 1517–1527PubMedCrossRefGoogle Scholar
  3. 3.
    Hargreave FE, Dolovich J, Newhouse MT (eds) (1990) The assessment and treatment of asthma. J All Clin Immunol 85: 1098–1111CrossRefGoogle Scholar
  4. 4.
    British Thoracic Society (1990) Guidelines for the management of asthma in adults. I. Chronic persistent asthma. Br Med J 301: 651–653CrossRefGoogle Scholar
  5. 5.
    National Institutes of Health Expert panel report (1991) Guidelines for the diagnosis and management of asthma. Publication no 91: 3042Google Scholar
  6. 6.
    Sheffer AL (ed) (1992) International Report. International Consensus Report on diagnosis and treatment of asthma. Eur Respir J 5: 601–641Google Scholar
  7. 7.
    Ryan G, Latimer KM, Dolovich J, Hargreave FE (1982) Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator therapy. Thorax 37: 423–429PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Quackenboss JJ, Lebowitz MD, Krzyzanowsky M (1991) The normal range of diurnal changes in peak expiratory flow rates: relationship to symptoms and respiratory diseases. Am Rev Respir Dis 143: 323–330PubMedCrossRefGoogle Scholar
  9. 9.
    Bousquet J, Chanez P, Lacoste JY et al (1990) Eosinophilic inflammation in asthma. N Engl J Med 323: 1033–1039PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1993

Authors and Affiliations

  • Leonardo M. Fabbri
    • 2
  • A. Papi
    • 1
  • P. Boschetto
    • 1
  • A. Ciaccia
    • 1
  1. 1.Istituto di Patologia GeneraleFerraraItaly
  2. 2.Istituto di Patologia GeneraleFerraraItaly

Personalised recommendations